Shares of Krsnaa Diagnostics Limited dropped 3.58% to Rs 836.05 on Tuesday, August 12, despite the company reporting strong financial performance for the first quarter of FY26. The decline is likely due to profit booking after recent gains in the stock.
For the April–June quarter, net profit rose 14.5% year-on-year (YoY) to Rs 20.5 crore from Rs 17.9 crore in Q1 FY25. Revenue increased 13.3% YoY to Rs 192.9 crore from Rs 170.2 crore, while EBITDA jumped 20.6% YoY to Rs 51 crore from Rs 42.3 crore. The EBITDA margin improved to 26.4% from 24.8% in the same period last year.
During Tuesday’s session, the stock traded between Rs 838.10 and Rs 868.00, compared to its previous close of Rs 867.05. Krsnaa Diagnostics currently has a market capitalization of Rs 27,280 crore and a price-to-earnings ratio of 35.70.
The strong results were driven by higher diagnostic volumes and operational efficiency gains, but short-term selling pressure from profit booking weighed on the share price.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
